OR WAIT null SECS
April 27, 2021
Pascal Descargues, Ph.D., founder of Genoskin, talks about how the company is responding to the US government’s push to help pharma and biotech leaders speed clinical drug development and testing.
Insights and examples of how collaborative efforts can lead to the development of innovative therapies that target unmet patient needs.
March 22, 2021
The shift to clinical-grade support offers great opportunity.
March 16, 2021
Dr. Matthias Schmidt talks about his new role leading the US subsidiary of Japan’s JCR Pharmaceuticals after a “far-from-easy” merger last year.
March 08, 2021
Presenting a structured, decision-making approach for executive management to make sound strategic decisions for drug development and life cycle management.
March 03, 2021
Francesca Properzi and Sudip Sinha talk about how the results of an inaugural Clinical Trial Digital Tracker Survey indicate that many clinical trials organizations are still reluctant to integrate digital technologies into their processes.
February 26, 2021
Decentralized tools and technologies will continue to provide new opportunities for patient engagement post-COVID.
February 12, 2021
R&D on medical treatments lags notable success with vaccines.
December 28, 2020
Jill Wechsler reports on FDA's newly published strategies supporting broader eligibility criteria for Phase III studies.
December 07, 2020
Utilizing natural language processing technologies to improve search capabilities and advance the development of therapies.
